202 related articles for article (PubMed ID: 29966512)
21. Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Nolan CR; Qunibi WY
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):373-9. PubMed ID: 12815333
[TBL] [Abstract][Full Text] [Related]
22. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Noto L
J Ren Nutr; 2011 May; 21(3):277-82. PubMed ID: 20598905
[TBL] [Abstract][Full Text] [Related]
23. Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.
Lorenzo Sellares V; Torres Ramírez A
Drugs Aging; 2004; 21(3):153-65. PubMed ID: 14979734
[TBL] [Abstract][Full Text] [Related]
24. Late Diagnosis of Congenital Hypothyroidism in Young Adult.
Pramono LA; Yuwono A
Acta Med Indones; 2019 Jul; 51(3):272-274. PubMed ID: 31699952
[TBL] [Abstract][Full Text] [Related]
25. Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
Ouellet G; Cardinal H; Mailhot M; Ste-Marie LG; Roy L
Ther Apher Dial; 2010 Apr; 14(2):172-7. PubMed ID: 20438539
[TBL] [Abstract][Full Text] [Related]
26. [Renal osteodystrophy (3); its treatment in dialysis patients].
Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
[TBL] [Abstract][Full Text] [Related]
27. Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality.
McCullough PA
Cardiorenal Med; 2021; 11(3):123-132. PubMed ID: 34120113
[TBL] [Abstract][Full Text] [Related]
28. Weekly Intramuscular Injection of Levothyroxine following Myxoedema: A Practical Solution to an Old Crisis.
Taylor PN; Tabasum A; Sanki G; Burberry D; Tennant BP; White J; Okosieme O; Aldridge A; Das G
Case Rep Endocrinol; 2015; 2015():169194. PubMed ID: 26618010
[TBL] [Abstract][Full Text] [Related]
29. Managing hypothyroidism during pregnancy.
Nikfar S; Koren G
Can Fam Physician; 2001 Aug; 47():1555-6. PubMed ID: 11561329
[TBL] [Abstract][Full Text] [Related]
30. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
[TBL] [Abstract][Full Text] [Related]
31. An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles.
Ogata H; Takeshima A; Ito H
Expert Opin Drug Saf; 2022 Jul; 21(7):947-955. PubMed ID: 35180026
[TBL] [Abstract][Full Text] [Related]
32. Phosphate binders in chronic kidney disease: an updated narrative review of recent data.
Floege J
J Nephrol; 2020 Jun; 33(3):497-508. PubMed ID: 31865608
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review.
Gasu V; Ashong M; Seferi A; Fitzpatrick A
JBI Database System Rev Implement Rep; 2019 Jan; 17(1):49-73. PubMed ID: 30204711
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
Tonelli M; Wiebe N; Culleton B; Lee H; Klarenbach S; Shrive F; Manns B;
Nephrol Dial Transplant; 2007 Oct; 22(10):2856-66. PubMed ID: 17906326
[TBL] [Abstract][Full Text] [Related]
35. Emerging drugs for hyperphosphatemia.
Bellinghieri G; Santoro D; Savica V
Expert Opin Emerg Drugs; 2007 Sep; 12(3):355-65. PubMed ID: 17874966
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients.
McIntyre CW; Patel V; Taylor GS; Fluck RJ
Nephrol Dial Transplant; 2002 Sep; 17(9):1643-8. PubMed ID: 12198217
[TBL] [Abstract][Full Text] [Related]
37. Carum induced hypothyroidism: an interesting observation and an experiment.
Naghibi SM; Ramezani M; Ayati N; Zakavi SR
Daru; 2015 Jan; 23(1):5. PubMed ID: 25616491
[TBL] [Abstract][Full Text] [Related]
38. Phosphate binders and timing of levothyroxine administration.
Arnadottir M; Johannesson AJ
Nephrol Dial Transplant; 2008 Jan; 23(1):420. PubMed ID: 17804456
[No Abstract] [Full Text] [Related]
39. Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial.
Ko SM; Zhang C; Chen Z; D'Marco L; Bellasi A; Stillman AE; Block G; Raggi P
J Nephrol; 2016 Oct; 29(5):683-90. PubMed ID: 27102490
[TBL] [Abstract][Full Text] [Related]
40. Phosphate binders in CKD: chalking out the differences.
Rees L; Shroff RC
Pediatr Nephrol; 2010 Mar; 25(3):385-94. PubMed ID: 19898877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
